May 15, 2018Diabetes Obesity and MetabolismOpen Access

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

View Full Paper

Ask AI

Bookmark

Abstract

In SUSTAIN 1 to 5, semaglutide-induced weight loss was consistently greater versus comparators, regardless of baseline BMI. The contribution of nausea or vomiting to this weight loss was minor.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Åhrén et al. (2018) studied this question.

synapsesocial.com/papers/69d7af323fae90fd6048fee7 https://doi.org/10.1111/dom.13353

View Full Paper

Ask AI

Bookmark

Abstract

In SUSTAIN 1 to 5, semaglutide-induced weight loss was consistently greater versus comparators, regardless of baseline BMI. The contribution of nausea or vomiting to this weight loss was minor.

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

Abstract

Discussion

Cite This Study

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

Abstract

Discussion

Cite This Study

Also Consider

Also Consider